Skip to main content
logo
SynAct Pharma AB (STO:SYNACT)
Sweden flag Sweden · Delayed Price · Currency is SEK
18.60
+0.10 (0.54%)
Jul 24, 2026, 4:25 PM CET

SynAct Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-116.79-0.25-89.98-224.5-105.71-76.7
Net Income
-110.83-2.7-82.4-215.81-99.21-69.3
Earnings Per Share
-2.17-2.17-2.08-6.64-3.60-2.68
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
53.4153.4161.2162.4108.2524
Total Debt
1.211.211.880.642.063.09
Net Cash (Debt)
52.252.259.3361.76106.1820.91
Net Cash Growth
-12.02%-12.02%-3.94%-41.84%407.85%43.72%
Net Cash Per Share
1.021.021.161.903.850.81

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-97.337.49-89.2-100.18-117.56-65
Free Cash Flow
-97.337.49-89.2-100.18-117.56-65
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
-160.96----